OMERS ADMINISTRATION Corp Has $82.51 Million Position in Intuitive Surgical, Inc. $ISRG

OMERS ADMINISTRATION Corp boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 291.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 145,679 shares of the medical equipment provider’s stock after buying an additional 108,465 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Intuitive Surgical were worth $82,507,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Silvant Capital Management LLC boosted its position in Intuitive Surgical by 0.3% during the fourth quarter. Silvant Capital Management LLC now owns 90,622 shares of the medical equipment provider’s stock valued at $51,325,000 after purchasing an additional 254 shares during the last quarter. Sofinnova Investments Inc. boosted its position in Intuitive Surgical by 14.5% during the fourth quarter. Sofinnova Investments Inc. now owns 126,968 shares of the medical equipment provider’s stock valued at $71,910,000 after purchasing an additional 16,072 shares during the last quarter. TritonPoint Partners LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $646,000. Truvestments Capital LLC boosted its position in Intuitive Surgical by 11.8% during the fourth quarter. Truvestments Capital LLC now owns 2,320 shares of the medical equipment provider’s stock valued at $1,314,000 after purchasing an additional 245 shares during the last quarter. Finally, USS Investment Management Ltd boosted its position in Intuitive Surgical by 1.9% during the fourth quarter. USS Investment Management Ltd now owns 61,201 shares of the medical equipment provider’s stock valued at $34,671,000 after purchasing an additional 1,117 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 1.3%

ISRG opened at $416.55 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $396.68 and a 12-month high of $603.88. The stock has a market cap of $147.53 billion, a price-to-earnings ratio of 50.49, a PEG ratio of 3.28 and a beta of 1.46. The business has a 50 day moving average of $442.17 and a 200-day moving average of $494.54.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.81 earnings per share. As a group, analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares in the company, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock worth $3,059,135 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Piper Sandler reissued an “overweight” rating and set a $580.00 price target on shares of Intuitive Surgical in a research report on Tuesday, June 2nd. Evercore cut their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research report on Monday, April 6th. Mizuho set a $525.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Finally, Jefferies Financial Group cut their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $571.28.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.